Ionis Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell IONS and other ETFs, options, and stocks.About IONS
Ionis Pharmaceuticals, Inc. engages in the development and commercialization of human therapeutic drugs using antisense technology. The company was founded by Stanley T.
CEOBrett P. Monia
CEOBrett P. Monia
Employees1,069
Employees1,069
HeadquartersCarlsbad, California
HeadquartersCarlsbad, California
Founded1989
Founded1989
Employees1,069
Employees1,069
IONS Key Statistics
Market cap6.36B
Market cap6.36B
Price-Earnings ratio-13.24
Price-Earnings ratio-13.24
Dividend yield—
Dividend yield—
Average volume2.13M
Average volume2.13M
High today$40.82
High today$40.82
Low today$39.72
Low today$39.72
Open price$40.32
Open price$40.32
Volume3.27M
Volume3.27M
52 Week high$52.34
52 Week high$52.34
52 Week low$23.95
52 Week low$23.95
IONS News
TipRanks 1d
Ionis Pharmaceuticals upgraded to Overweight from Equal Weight at BarclaysBarclays upgraded Ionis Pharmaceuticals (IONS) to Overweight from Equal Weight with a price target of $57, up from $51, ahead of Tryngolza Phase 3 CORE/CORE2 da...
Analyst ratings
71%
of 28 ratingsBuy
71.4%
Hold
25%
Sell
3.6%
People also own
Based on the portfolios of people who own IONS. This list is generated using Robinhood data, and it’s not a recommendation.